Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab
Clinical trial NCT06107413 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06107413
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-12
- Primary completion
- 2026-12-01
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.